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Abstract
In the fission yeast the prevailing approach forSchizosaccharomyces pombe 
gene manipulations is based on homologous recombination of a PCR product
that contains genomic target sequences and a selectable marker. The
CRISPR/Cas9 system has recently been implemented in fission yeast, which
allows for seamless genome editing without integration of a selection marker or
leaving any other genomic ‘scars’. The published method involves manual
design of the single guide RNA (sgRNA), and digestion of a large plasmid with
a problematic restriction enzyme to clone the sgRNA. To increase the efficiency
of this approach, we have established and optimized a PCR-based system to
clone the sgRNA without restriction enzymes into a plasmid with a dominant 
(nourseothricin) selection marker. We also provide a web-tool,natMX6  
CRISPR4P, to support the design of the sgRNAs and the primers required for
the entire process of seamless DNA deletion. Moreover, we report the
preparation of G1-synchronized and cryopreserved  cells, whichS. pombe
greatly increases the efficiency and speed for transformations, and may also
facilitate standard gene manipulations. Applying this optimized
CRISPR/Cas9-based approach, we have successfully deleted over 80 different
non-coding RNA genes, which are generally lowly expressed, and have
inserted 7 point mutations in 4 different genomic regions.
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            Amendments from Version 1
We have edited or added details in several places throughout the 
text to clarify the message. We have included a new relevant  
reference by Fernandez and Berro. We provide updated versions 
of Figure 2, Figure 4 and Figure 5 to improve data presentation, 
and provide a new section C for Figure 6 to show the chromo-
somal locations of the deleted non-coding RNA genes. We also 
provide a new Supplemental Figure 2 which contains the data 
used for the graphs in Figure 6A and B.
See referee reports
REVISED
Introduction
The fission yeast Schizosaccharomyces pombe is a potent genetic 
model organism. Gene deletions and other genetic manipulations 
in S. pombe are most commonly performed in a single-step by 
transformation of a PCR product, which includes a selectable marker 
gene along with flanking regions to target the genomic region 
to be manipulated1. Several techniques have been developed to 
circumvent complications caused by selectable markers, includ-
ing the LoxP-Cre recombinase system2, the rpl42 (cycloheximide 
resistance)-based method3,4, the pop-in/pop-out methods5, a 
CRISPR method based on fluoride resistance6, or a recent method 
for scar-less gene tagging7. However, these methods have draw-
backs that limit their applicability: they either involve two trans-
formations or selection steps, leave ‘DNA-scars’, affect cellular 
physiology, or can only be used in specific genetic backgrounds.
The recent emergence of the prokaryotic CRISPR/Cas9 system for 
genome editing now provides the opportunity for efficient gene 
manipulation without any markers8–10. Such seamless genome edit-
ing offers several advantages: 1) it allows targeting of multiple 
genetic manipulations to the same strain without restrictions due 
to markers or any marker recycling; 2) it avoids indirect physio-
logical effects, which accompany some markers (11; M. R.-L. and 
C. C., unpublished observations); and 3) it limits the perturba-
tion of the local chromatin and transcriptional environment to the 
gene manipulation of interest.
The CRISPR/Cas9 genome editing system has recently been 
implemented in fission yeast by applying the promoter/leader 
sequence of K RNA (rrk1) and a hammerhead ribozyme to express 
the single guide RNA (sgRNA)12. The Cas9 protein acts as an 
RNA-guided endonuclease that binds to a protospacer adjacent 
motif (PAM) site and introduces a double-strand break (DSB) 
three base pairs upstream of the PAM site in the spacer sequence. 
The cell can then repair this DSB either by non-homologous end 
joining, which will introduce point mutations or indels, or by 
efficient homologous recombination if the cell is provided with 
a suitable template. This approach allows for the precise editing 
of genomic locations without the need of any selectable marker, 
since cells that do not repair the DSB will die. Genome editing in 
S. pombe with CRISPR/Cas9 involves the manual identification of 
unique PAM and spacer sequences (sgRNA) and cloning of these 
sequences into an expression plasmid with a CspCI restriction site 
to produce the sgRNA. Overexpression of the Cas9 enzyme is det-
rimental for S. pombe growth, which is partially circumvented by 
co-expression of the sgRNA and Cas9 from the same plasmid12. 
However, the resulting large plasmid (~11 kb) is difficult to work 
with, and the CspCI digestion required for cloning is often very 
inefficient. Accordingly, we and others have encountered serious 
problems in implementing the CRISPR/Cas9 system.
Here, we present a PCR-based, rapid and efficient method for the 
seamless deletion of any DNA sequence in the S. pombe genome, 
or other genome manipulations, such as point mutations, by apply-
ing modifications and optimizations of the CRISPR/Cas9 system. 
We also provide the CRISPR4P web tool to design the different 
types of primers required for deletion of any genomic region: PCR-
based sgRNA cloning, PCR-based synthesis of DNA template for 
deletion by homologous recombination, and checking primers to 
confirm the deletion. Furthermore, we have modified a protocol for 
the generation of cryopreserved S. pombe cells13, by implement-
ing G1 synchronization and optimizations, which substantially 
increases the efficiency of successful transformations, especially for 
regions that are difficult to delete. This protocol may also facilitate 
the manipulation of genomic regions using the traditional method1.
Overview of approach
The main steps of the CRISPR/Cas9-based method to generate 
gene deletions are briefly highlighted below. Figure 1 provides a 
flow diagram of the main steps. A more detailed methodology is 
available at the end of the manuscript and as a PDF in Supple-
mentary File 1. The entire procedure takes about 8 days, including 
about 5 days for incubation.
1.    Identify suitable sgRNAs to target region of interest using 
CRISPR4P tool14 (bahlerlab.info/crispr4p) (Figure 2).
2.    Design of primers required for whole process using 
CRISPR4P (Figure 3A): 1) sgRNA cloning; 2) synthesis 
of DNA template for homologous recombination (HR tem-
plate) for gene deletion; and 3) checking primers to con-
firm gene deletion.
3.    Clone sgRNAs into nourseothricin-selectable plasmid 
pMZ379 that contains Cas9 enzyme gene, the natMX6 
selection marker and the rrk1 promoter/leader (Figure 3B; 
Figure 4).
4.    Generate HR template by PCR using primers with 
sequences flanking the region of interest and overlapping 
at their 3’ ends (Figure 3C).
5.    Delete region of interest by co-transforming sgRNA/Cas9-
plasmid and HR template into S. pombe cells that have 
been synchronized and cryopreserved to increase transfor-
mation efficiency (Figure 3D).
6     Select the smallest colonies from selective plate 
(Figure 3E) and check these colonies for deletion junction 
by colony PCR (Figure 3F).
Note that this approach can be adapted for applications other 
than gene deletions, such as insertion of point mutations or tags. 
The CRISPR4P tool allows the user to identify possible sgRNA 
sequences in any region of interest for other applications of the 
CRISPR/Cas9-based genome editing.
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Design of sgRNA
The sgRNA targets the Cas9 enzyme to its recognition site to 
generate a DSB upstream of the PAM sequence. However, it 
has been reported that Cas9 can also generate DSBs in other 
genomic sequences that contain a few mismatches compared to 
the sgRNA17,18, and even in sites that cannot be predicted simply 
by sequence homology19. Thus, it is important to choose a suitable 
target region to maximize the specificity and avoid undesirable 
off-target effects. Mismatches within the 12 nucleotide ‘seed’ 
sequence, immediately upstream of the PAM sequence, reduce 
the nuclease activity of the Cas9 enzyme, and must therefore be 
avoided for the target sequence20. On the other hand, such 
mismatches in similar sequences elsewhere in the genome will 
reduce the likelihood of Cas9 targeting. Multiple tools are becom-
ing available for the prediction of sgRNAs and off-target effects 
(see 21 for a review), but not all include the S. pombe genome, 
and there have been no studies into the issue of off-target effects 
in S. pombe. CRISPR4P facilitates the design of sgRNAs and pro-
vides basic information on the similarity of sgRNA sub-sequences 
to other genomic sgRNA sequences to minimize off-target effects. 
In the case of gene deletions, there is considerable flexibility with 
respect to sgRNA selection because the targeting is not limited to 
a narrow region.
CRISPR4P has scanned the S. pombe genome, downloaded from 
PomBase, for all possible 3-nucleotide Streptococcus pyogenes 
Cas9 PAM sites (5’-NGG-3’), and stored this information together 
with the sequences of the 20 nt upstream of all these PAM sites 
(sgRNA sequences), thus generating a database of all possible 
genomic sgRNAs plus PAM sites. Users can input their target 
regions either by gene name or genomic coordinates, with the 
latter providing the flexibility to delete any region of interest, such 
as regulatory sequences, non-coding RNAs, or specific sub-regions 
of genes. If the input is a gene name, the coordinates of the cod-
ing sequence are calculated based on PomBase annotation (genome 
assembly ASM294v2, version 55) (http://www.pombase.org/)22,23. 
CRISPR4P then examines the nucleotide string within the input 
coordinates of the target sequence for PAM sites along with the 
upstream 20 nt sgRNAs using the genomic database of all sgRNAs 
plus PAM sites. CRISPR4P is not an off-target scorer, but helps 
users in the selection of suitable sgRNAs, based on basic concepts 
of similarity to other regions. Our premise is that the chosen 20 nt 
sgRNA should be unique in the genome, and only unique sgRNAs 
will therefore be provided in the output. In addition, CRISPR4P 
then presents all the possible sgRNAs in the target region, ranked by 
similarity to other putative sgRNAs anywhere in the genome. The 
data to the right of each sgRNA indicates the numbers of genomic 
sgRNA sequences that share a given number of nucleotides (starting 
from the 5’ end of the PAM sequence), scanning the sgRNA from 
8 bp up to 20 bp every 2bp. To minimize any off-target effects, the 
12 nt ‘seed’ sequence immediately upstream of the PAM site should 
ideally be unique in the genome. Furthermore, we do recommend 
the use of at least two different sgRNAs for any given deletion con-
struct and to test the phenotypes of several independent deletion 
strains from each transformation. Any specific off-target mutation 
is unlikely to occur independently in different clones, and even less 
likely to occur with different sgRNAs.
Figure  1.  Flow  diagram  for  CRISPR/Cas9-based  approach  for 
seamless genome editing in fission yeast. sgRNA, single guide 
RNA.
CRISPR4P primer design tool
Available primer design programs for gene targeting in S. pombe 
allow the manipulation of coding sequences using the standard 
PCR-based method15, or rely on current gene annotations to gen-
erate a database that contains primers for deletion of non-coding 
RNAs, 3’-UTRs or tRNAs16. We have designed an online tool, writ-
ten in Python 2.7 (www.python.org/), to help with the design of 
all the different primers required for CRISPR/Cas9-based deletion 
of virtually any region in the S. pombe genome. This tool, named 
CRISPR4P (CRISPR ‘for’ Pombe or CRISPR Pombe PCR Primer 
Program), is freely available from our website (bahlerlab.info/
crispr4p)14. CRISPR4P designs PCR primers for sgRNA cloning 
and primers to generate the HR template, and also checks prim-
ers to verify gene deletions. Figure 2 provides an overview of the 
workflows for CRISPR4P, and Figure 3A provides an overview of 
the different primers that can be designed by CRISPR4P.
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Figure 2. Overview of workflows for CRISPR4P tool for sgRNA and PCR primer design. sgRNA, single guide RNA; PAM, protospacer 
adjustment motif. In the table ‘Suggested sgRNAs’, the numbers of genomic sgRNA sequences that share a given number of nucleotides are 
indicated to the right of each sgRNA. See main text for details.
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A specific sgRNA can be selected by clicking the round button 
to the left of the sequence; CRISPR4P will then provide the cor-
responding outputs at the bottom, including the sgRNA sequence 
together with its coordinates and the two primer sequences 
required to clone the sgRNA into the plasmid pMZ379 by PCR 
(Figure 3A and B). CRISPR4P also provides two other sets of 
PCR primers described below.
Primer design for HR template
CRISPR4P selects 80 nt up- and down-stream of the target 
sequence to be deleted and joins these sequences together into a 
160 nt long HR template sequence to target the region of interest 
for seamless deletion by homologous recombination. This 
‘junction’ sequence is then used to design the primers to generate 
the HR template DNA by PCR amplification (Figure 3A and C). 
The forward primer (HRfw) contains the 100 nt from the 5’-end 
of the HR template, and the reverse primer (HRrv) are the reverse 
complementary 100 nt from the 3’-end of the HR template. We 
have found that 20 nt of overlapping region between these two PCR 
primers are sufficient to generate the HR template.
Primer design to check deletion junction
CRISPR4P also provides two PCR primers to check the seamless 
deletion junction. These primers are positioned up- and down-stream 
Figure 3. Scheme of key steps for CRISPR/Cas9-based method and primer design. sgRNA, single guide RNA.
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of the HR template region. First, CRISPR4P generates in silico 
a region surrounding the deletion junction by joining the 250 nt 
immediately up- and down-stream of the junction. This sequence 
is then used as the input for the Python implementation of 
Primer3 (http://primer3.ut.ee/)24 to design checking primers 
(Figure 3A and F). The output of this third module is the region 
surrounding the deletion junction (which can be used for veri-
fication of the junction by DNA sequencing), the two checking 
primers with their melting temperatures (Tm), and the expected 
sizes of the PCR products obtained for either successful deletion 
or without deletion (wild-type).
Rationale for optimization of experimental protocols
Cloning of sgRNA
Since the CspCI digestion of the plasmid containing Cas9 and the 
rrk1-guided sgRNA is often inefficient, it can be very difficult to 
clone sgRNAs into the plasmid optimized for CRISPR/Cas9 gene 
editing in S. pombe. We therefore devised alternative approaches 
for the introduction of the sgRNA into the pMZ379 plasmid 
(available through Addgene; plasmid no., 74215). The new Cas9-
sgRNA plasmid pMZ379 contains a dominant selection marker 
that does not rely on auxotrophy (Figure 4). This plasmid ena-
bles the application of the CRISPR-Cas9 technique in any genetic 
background. Moreover, we have observed that the use of auxo-
trophic markers, such as ura4, can lead to undesirable physiological 
side effects (M.R.-L. and J.W., unpublished observations), as also 
observed for S. cerevisiae11.
The first method introduces the sgRNA sequence via the 5’ 
ends of the primers used for PCR amplification of the pMZ379 
plasmid sequence, followed by phosphorylation and ligation of the 
PCR product to reconstruct a new circular plasmid containing the 
desired sgRNA. We provide detailed PCR optimizations and other 
methods to deal with the large (~11kb) pMZ379 plasmid, which 
are critical for the success of the approach. Moreover, we cur-
rently optimize a second, alternative method that involves a generic 
PCR reaction to amplify the pMZ379 plasmid without introducing 
the sgRNA, followed by cloning of the sgRNA into the plasmid 
by cloneEZ or Gibson Assembly with annealed primers that con-
tain the sgRNA sequence and flanking regions homologous to the 
ends of the PCR product. We are also planning to introduce a NotI 
restriction site for efficient linearization of the pMZ379 plasmid 
without PCR reactions to facilitate large-scale cloning. These 
methods will be added to udpated versions of the paper as they are 
developed.
G1 synchronization and cryopreserved competent cells
The activity of the prokaryotic Cas9 enzyme is likely increased 
in sites with more accessible chromatin and lower nucleosome 
occupancy. In mammalian cells, for example, Cas9 is more 
effective for sgRNAs that target coding sequences where chro-
matin is more open compared with other regions25. This could 
cause problems for deleting or editing poorly transcribed and 
inaccessible regions, as we have observed for several non-coding 
RNAs (M.R.-L., C.C. and N.B.B., unpublished data),. Moreover, 
Figure 4. Map of pMZ379 plasmid. The primers to clone sgRNA are indicated by purple arrows. The primers for sequencing insertion of 
sgRNA are indicated by green arrows. Image adapted from snapGene viewer. sgRNA, single guide RNA.
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Figure 5. Improved transformation using G1-synchronized, cryopreserved cells. Wild-type cells were cultured in EMM medium and either 
subjected to nitrogen starvation for 2 hrs (synchronous) or maintained on normal EMM medium (asynchronous) at 25°C. The same number 
of cells were then made competent and frozen for synchronous and asynchronous cultures. Cryopreserved synchronous and asynchronous 
cells were transformed with the same amount of DNA for two different sgRNAs, as indicated at top and left. Cells were incubated at 32°C 
for 4 days, revealing a greatly increased transformation efficiency of the synchronous cells, with no colonies present for unsynchronized 
cells. Transformation of synchronous cells consistently resulted in 3-fold to over 1000-fold higher numbers of colonies than transformation of 
asynchronous cells.The enlarged image indicates the smallest colonies that are much more likely to contain successful deletions (red circles) 
than the large colonies (yellow circles).
proliferating S. pombe cells spend most of their time in G2 phase 
with a 2C DNA content. In these cells, two genomic copies need to 
be successfully modified by CRISPR/Cas9, and if only one copy 
is modified, the wild-type copy could be used as a template for 
homologous repair of the DSB. Therefore, it is likely that the effi-
ciency of CRISPR/Cas9 genome editing is increased in G1 cells 
that contain a 1C of DNA.
Having these issues in mind when encountering low efficiencies 
for the CRISPR/Cas9 system, we implemented the synchroniza-
tion of S. pombe cells in G1 using a simple nitrogen starvation 
protocol. This treatment not only greatly increases the proportion 
of cells with a 1C DNA content, but also substantially remod-
els the transcriptional programme26,27, which can render many 
genomic regions more accessible. Moreover, we optimized a pro-
tocol for cryopreservation of competent, G1-synchronized cells13, 
which greatly improves transformation and deletion efficiencies. 
Accordingly, we observed dramatically enhanced transforma-
tion rates when using G1-synchronized and cryopreserved cells 
(Figure 5).
Application of CRISPR/Cas9-based approach
Using this optimized approach, we have deleted over 80 non- 
coding RNA genes 36 of which were deleted using 2 different 
sgRNAs (all primers for the deletions can be found in Supple-
mentary Table 1). The efficiencies for successful deletions vary 
considerably for different genes (Figure 6A) and for differ-
ent sgRNAs targeting the same gene (Figure 6B), with success 
rates ranging from 3% to 100%. For example, for the deletion 
of SPNCRNA.745, we obtained 5% positive colonies with one 
sgRNA (sgRNA.745.2) and 64% positive colonies with another 
one (sgRNA.745.3). Thus, using at least 2 different sgRNAs per 
deletion not only minimizes the risk of being misled by phenotypes 
from off-target effects but it also maximizes the chance of success-
ful deletion. The deleted non-coding RNA genes were spread across 
all 3 chromosomes (Figure 6C).
We have also successfully and efficiently introduced 7 point 
mutations in 4 different genomic regions using the CRISPR/Cas9 
system, without leaving any other scars in the genome. Sites can 
only be mutated if they are located within the first 8–10 nt upstream 
of the PAM site. If no PAM site is available within this distance, 
a workaround could be applied by inserting two mutations as 
follows: use the HR template to introduce a synonymous change 
8–10 nt upstream of the nearest PAM site, to prevent re-cutting by 
Cas9, plus the desired mutation where required. Mutagenesis is a 
particularly attractive application of the CRISPR/Cas9 method. In 
principle, the CRISPR/Cas9 system could also be adapted to tag 
genes, but we have not yet tried this out.
The CRISPR4P tool greatly facilitates the design of the sgRNAs 
and the different sets of primers required for the entire approach. 
The sgRNAs designed by CRISPR4P generally showed much 
higher success rates than manually designed sgRNAs. The cur-
rent version of CRISPR4P only provides primers for deletion of 
genomic regions using the CRISPR/Cas9 system. However, 
CRISPR4P can be used to design sgRNAs to generate point 
mutations by inputting the coordinates of the region of interest. In 
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Figure 6. Deleting non-coding RNAs using CRISPR/Cas9-based approach. (A) Percentage of successful deletions among all sgRNAs that 
yielded at least one successful deletion for different non-coding RNA genes, with data from 120 different deletions aggregated. (B) Data on 
efficiencies of successful deletions for 36 non-coding RNA genes, for transformation with different sgRNAs (color-coded 2-4). In these cases, 
sgRNA1 were designed manually and did not yield successful deletions, whereas the sgRNAs 2-4 designed by CRISPR4P proved to be 
largely successful, and sgRNA4 were used for the two genes where sgRNA2 did not work. Note the greatly varying success rate for different 
genomic loci and for different sgRNAs.The data used for the graphs in (A) and (B) are provided in Supplementary Table 2. (C) Genomic 
locations of all annotated non-coding RNA genes (small grey dots) and the non-coding RNA genes which we have deleted (red dots).
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future work, we are assembling a database with all sgRNAs used, 
whether they worked or not, to help with learning the principles for 
successful sgRNAs in S. pombe.
 
  Help box 1. How to use the CRISPR4P tool
•      Input region to be deleted, either by Gene name (e.g., cdc2 
or SPNCRNA.01) or by Coordinates (e.g., Chromosome: II; 
Coordinates: from 1500340 to 1501528).
•      Output list of sgRNAs is ordered by similarity to other genomic 
sgRNAs, with most unique sgRNA on top; select sgRNA by 
clicking on radial button at left.
•      Output provides 3 types of primers
o   Primers for sgRNA cloning depending on selected sgRNA.
o   Primers to generate HR template.
o    Primers for checking the deletion construct, along with 
melting temperatures and expected sizes (in nt) of PCR 
products for successful deletion or without deletion, and 
along with sequence surrounding the deletion junction.
 
   Help box 2. Important steps for successful application of CRISPR/
Cas9
•     Select at least 2 sgRNAs per construct with low similarity to other 
genomic regions.
•     The large pMZ379 plasmid is unstable: aliquot and store at -80°C 
(do not thaw and re-freeze aliquots).
•     To avoid generation of partial plasmids during PCR reaction, 
optimized PCR conditions are required: Phusion High Fidelity 
mastermix, 60ºC annealing temperature, 2% DMSO, 1 ng  
(40 fg/µl) of pMZ379 template, 25 PCR cycles.
•     Use high-fidelity polymerase to amplify plasmid and HR 
templates.
•     After bacterial transformation of sgRNA plasmid, perform ‘E. coli 
micro-cultures’ to reduce number of minipreps.
•     Check for correct sgRNA by sequencing Cas9-sgRNA plasmid 
with M13F primer.
•     Synchronize S. pombe cells for 2 hrs in EMM without nitrogen 
before making them competent to increase efficiency of 
transformation, reduce incubation times, and facilitate deletion of 
difficult genomic regions.
•     To support homologous recombination of HR template, incubate 
cells for 16 hours in EMM without nitrogen after transformation 
which avoids need for first plating cells onto YES before replica-
plating on selective media (common practice for antibiotic 
markers selection) and thus prevents cells from proliferating.
•     Select smallest colonies from transformation as these are most 
likely to contain correct deletions. Positive colonies typically 
appear only 4 days or later after plating, while colonies growing 
faster are typically negative for the deletion.
Methods
Reagents and equipment
▪   pMZ379 plasmid (Addgene, plasmid # 74215)
▪    Phusion® High-Fidelity PCR Master Mix with HF Buffer (NEB, 
cat. no. M0531S) 
 CAUTION: this product contains DMSO which is known to be 
harmful for aquatic life, discard appropriately. 
▪   TopTaq Polymerase (QIAGEN, cat. no. 200201)
▪   dNTPmix 10 µM (Bioline, cat. no. BIO-39044)
▪   5× DNA Loading Buffer Blue (Bioline, BIO-37045)
▪    ExoSAP-IT PCR Product Cleanup (Affymetrix, cat. no. 78200 
200 UL)
     CAUTION: this product is irritant and can cause severe eye 
damage, wear protective eye wear. 
▪    Sodium acetate 3M (Thermo Fisher Scientific, cat. no. 
AM9740)
▪    Ethanol (MERCK, cat. no. 1.08543.0250)
▪   T4 Polynucleotide Kinase (NEB, cat. no. M0201S)
▪   T4 DNA ligase (NEB cat. no. M0202S)
▪    Mix & Go Competent Cells - Strain DH5α, 96 × 50 µl 
(Cambridge Bioscience, cat. no. T3009
▪   QIAprep Spin Miniprep Kit (QIAGEN, cat. no. 27104)
     CAUTION: Buffers P2 and N3 are corrosive and causes skin and 
eye damage/irritation, wear eye protection and gloves. Buffer PB 
is highly flammable and causes skin and eye irritation, and pos-
sibly dizziness. Keep away from fire, wear protective clothing and 
eye wear. Avoid inhalation of RNase A. 
▪   Herring sperm DNA 10 µg/µl (Promega, cat. no. D1811)
▪    Lithium Acetate dihydrate (Sigma-Aldrich, cat. no. 
L-4158-250g)
▪    Gycerol (Fisher Scientific, cat. no. BP229-1)
     CAUTION: irritant, wear protective eye wear gloves and 
clothing. 
▪    Polyethylene glycol 4000 (PEG4000) (VWR cat. no. 
26606.293)
▪    Nourseothricin-dihydrogen sulfate (Werner BioAgents cat. no. 
5.002.000)
     CAUTION: this product is harmful if swallowed, wear protective 
clothing and eye wear. 
▪    LB Broth Base w/o Trace elements (Formedium, cat. no. 
AIMLB0110)
▪    Agar powder (VWR, cat. no.20767.298)
▪    Ampicillin (Sigma, cat. no.A9518-25g)
     CAUTION: might cause skin irritation and respiratory problems, 
wear protective eye wear, gloves and avoid inhalation. 
▪    YES BROTH (Formedium, cat. no.PMCUCL1000)
▪    EMM BROTH W/O NITROGEN (Formedium, cat. no. 
PMD1310)
▪    NH4Cl (Sigma, cat. no. 09718/1kg)
     CAUTION: NH4Cl is toxic if swallowed, can cause eye irritation, 
wear protective clothing and eye wear. 
▪    Ultrapure Agarose (THERMO FISHER, cat. no. 16500500)
▪    10X Ultrapure TBE buffer (Life tech, cat. no. 15581044)
     CAUTION: can cause damage in the unborn child, may cause 
fertility problems, wear protective clothing and eye wear. 
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▪    HyperLadder 1kb (Bioline, cat. no. BIO-33053)
▪    Freeze 'N Squeeze™ DNA Gel Extraction Spin Columns 
(Bio-Rad, cat. no. 7326166)
Primer M13F: tgtaaaacgacggccagt
Step-by-step procedure (can be downloaded as Supplemental 
File 1)
Selection of sgRNAs and primers to delete region of interest 
1.  Use CRISPR4P (bahlerlab.info/crispr4p) to input desired deletion 
target by gene name or by coordinates as chromosome (in roman 
numeral), start and end sites. Select sgRNA by clicking button at 
left to display primers required for this sgRNA. We have found 
that there is no need for HPLC-purified oligos, desalted oligonu-
cleotides synthetized by our usual provider (Life Technologies) 
work well for the entire procedure, substantially reducing the 
cost of the deletions.
 CRITICAL STEP: CRISPR4P allows selection from all 
unique sgRNAs present within the input target region. The 
sgRNAs are ranked from least likely to most likely to have 
off-target effects, based on similarity of sub-sequences to 
other genomic sgRNAs. It is recommended to choose at least 
two sgRNAs from the top of the list.
Cloning sgRNA into pMZ379 plasmid (TIME: ~9 hours) 
2. Prepare master mix for PCR to clone sgRNA into pMZ379 
plasmid as in table below.
Use sgRNA cloning primers designed by CRISPR4P
Final  
concentration
Volume per 
reaction (25 
µl)
pMZ379 DNA (1 ng/µl)  
Primer mix (10 µM per primer)  
Phusion HF-buffer (2X)  
DMSO (100%)  
H2O
1 ng (40 fg/µl)  
0.4 nM/primer  
1×  
2% 
1 µl  
1 µl  
12.5 µl  
0.5 µl  
10 µl
 CRITICAL STEP: pMZ379 is unstable and should be 
stored in 1 ng/µl aliquots at -80°C, discard after thawing.
3. Perform PCR following protocol below.
Number of  
cycles
Temperature Duration
1  
25  
 
 
1
98ºC  
98ºC  
60ºC  
72ºC  
72ºC
2 min  
10 sec  
30 sec  
5 min 30 sec  
5 min
 CRITICAL STEP: PCR conditions have been adjusted for 
Phusion High-Fidelity Polymerase to minimize number of 
unspecific PCR bands (Figure 7A, B).
4.   Check PCR products by running 5 µl on 0.7% agarose TBE gel 
(Figure 7A).
5.   Optional step: Add 8 µl of ExoSAP-IT PCR Product Cleanup 
to 20 µl of PCR reaction. Incubate in PCR machine for 15 min at 
37°C and for 15 min at 80°C. 
6.   Precipitate DNA by adding 60 µl of 100% ethanol and 6 µl of 
3M sodium acetate.
7.  Incubate 30 min at -20°C.
8.   Centrifuge for 20 min at 20,000g, 4°C to precipitate PCR 
product.
9.  Remove supernatant.
10. Add 50 µl of 70 % ethanol (do not resuspend pellet).
11. Centrifuge for 10 min at 20,000g, 4°C.
12. Remove supernatant and air dry pellet.
13. Resuspend pellet in 20 µl of H20.
 PAUSE POINT: PCR product can be stored at -20°C until 
further processing.
14. Phosphorylate the 5’ ends of PCR product by preparing master 
mix as below.
µl per reaction in 
30 µl final  
volume
PCR product  
T4 DNA ligase buffer 
T4 PNK  
H2O
20  
3  
1  
6
 CRITICAL STEP: DNA ligase buffer is used because it 
provides the ATP required for the phosphorylation reaction 
(as recommended by manufacturer), and this enzyme exerts 
100% activity in this buffer.
15. Incubate 30 min at 37°C.
16. Inactivate the enzyme by incubating for 20 min at 65°C.
 PAUSE POINT: Phosphorylated DNA can be stored at -20°C 
until further processing.
17. Ligate plasmid ends by preparing master mix below
µl per reaction in 
10 µl final 
volume
Phosphorylated DNA  
T4 DNA ligase buffer  
T4 DNA ligase
8  
1  
1
18.  Ligate for 16 hrs at 16°C.
 PAUSE POINT: Ligated DNA can be stored at -20°C until 
further processing.
Transformation of chemically competent E. coli cells (TIME: 30 min) 
Cambridge Bioscience Mix & Go Competent Cells can be 
transformed using a short protocol provided by manufacturer.
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19.   Prepare LB-agar plates containing 75 µg/ml of ampicillin, and 
incubate them at 37°C for 15 min.
20.   Thaw one aliquot (per transformation) of Mix & Go 
Competent Cells (DH5α strain) on ice.
21.   Add 5 µl of ligated plasmid to cells, mix gently by tapping with 
finger.
CRITICAL STEP: Do not pipette competent cells.
22.   Incubate cells on ice for 5 min.
23.   Plate whole mixture of cells and DNA onto pre-warmed (37°C) 
LB-ampicillin plates.
24.  Incubate plates for 20 hrs at 37°C.
Confirmation of sgRNA cloning (TIME: ~2 days) 
Smaller, unspecific products during PCR amplification can lead 
to cloning mistakes (Figure 7A). But even in the absence of such 
unspecific PCR products, the plasmid can recombine during 
cloning, which results in aberrant sizes. To confirm that the 
sgRNA has been cloned correctly and that there are no mutations 
or rearrangements, we recommend to test about 12 colonies for 
each transformation by performing an ‘E. coli micro-cultures’, as 
follows.
25.   Prepare ‘E. coli micro-culture’ plate by adding 30 µl of 
LB + 75 µg/ml of ampicillin onto each well of a sterile 96-well 
plate.
26.  Inoculate different transformant in each well.
27.  Close plate with adhesive seal.
28.  Incubate cells for 20 hrs at 37°C.
Figure 7. PCR cloning of sgRNA into pMZ379 plasmid and ‘E. coli micro cultures’. (A) Gel of non-optimized PCR reactions for sgRNA 
cloning. Red arrows indicate shorter, unspecific products that need to be removed to avoid faulty plasmids. (B) As in (A), but with optimized 
PCR reaction which eliminates unspecific products (see protocol for details). (C) Gel of sgRNA-pMZ379 plasmid using non-optimized PCR 
reactions for sgRNA cloning. Each well contains DNA from different colony of same transformation. Red arrows indicate faulty cloning 
reactions containing plasmids of different sizes. (D) As in (C), but with optimized PCR reaction used for cloning which largely prevents faulty 
cloning reactions.
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29.   Prepare new 96-well plate with 30 µl of LB + 75 µg/ml of 
ampicillin on each well.
30.   Make replica of bacterial micro-culture plate onto the new plate 
by inoculating 5 µl of original micro-culture into new plate, 
seal and incubate it at 37°C.
31.   Boil original bacterial micro-culture plate for 10 min at 98°C 
in PCR machine.
32.  Let it rest for 2 min at 4°C.
33.   Mix with appropriate volume of loading buffer for each well 
(e.g. 5 µl of 5× loading buffer).
34.   Run 20 µl of bacteria-loading buffer mix on 0.7% agarose TBE 
gel to check for appropriate plasmid size.
 CRITICAL STEP: This step will allow to identify plas-
mids of the wrong size, so that only plasmids of the correct 
size are selected to test by sequencing (Figure 7C, D).
35.   Prepare 5 ml inoculums of bacteria containing clones of 
correct size on LB + 75 µg/ml of ampicillin. Cells are taken 
from replica plate of ‘E. coli micro-culture’. We normally 
check 1–2 transformants by sequencing.
36.  Incubate for 20 hrs at 37°C.
37.   Prepare glycerol stock of bacteria by mixing 500 µl of bacterial 
culture with 500 µl of 50% sterile glycerol, and store at -20°C.
38.   With remaining 4.5 ml of bacterial culture perform a ‘mini 
prep’ with QIAprep Spin Miniprep Kit.
39.   Quantify plasmid DNA and send for Sanger sequencing to 
confirm that correct sgRNA has been cloned. Use primer 
M13F (TGTAAAACGACGGCCAGT) for sequencing.
 PAUSE POINT: Plasmids and glycerol stocks can be stored 
at -20°C until sequence has been confirmed.
 CRITICAL STEP: In case of ligation-mediated sgRNA 
cloning, the last base pair next to the junction point 
is deleted in rare cases, leading to 19 nt sgRNA, so it is 
advisable to check 1–2 colonies for each sgRNA clone to 
ensure the appropriate sequence of the sgRNA.
Generation of HR template (TIME: ~ 2.5 hrs) 
40. Prepare PCR mastermix as in table below.
final  
concentration
Volume to add 
for 1 
reaction (50 µl)
HR primer mix (10 µM per  
primer) 
Phusion HF-buffer (2X) 
H2O
0.4 nM/primer 
1x
 
2 µl  
25 µl  
23 µl
41.  Perform PCR following protocol below.
Cycles Temperature Duration
1 cycle 
30 cycles 
 
 
1 cycle
98°C  
98°C  
55°C  
72°C  
72°C
2 min  
10 sec  
10 sec  
30 sec  
5 min
42. Check PCR products by running 5 µl on 1.5 % agarose TBE gel.
PAUSE POINT: HR template can be stored at -20°C.
Preparation of synchronized competent cryopreserved S. pombe 
cells (TIME: ~1.5 days) 
This protocol is a modification of a previously described 
method13 to prepare 200 ml of competent cells that allows for 40 
transformations.
43.   Prepare 20 ml preculture in EMM and grow cells by shaking at 
32°C for 8–16 hrs.
44.   Dilute cells in 200 ml EMM and grow cells until they reach 
mid-exponential phase (~2 × 109 cells in total).
45.   Centrifuge cells for 3 min at 1800g, room temperature.
46.   Remove supernatant.
47.   Wash in one volume (200 ml) of EMM without nitrogen 
(EMM-N).
48.  Repeat steps 45 and 46 once more.
49.   Resuspend cells in 200 ml of EMM-N and transfer to sterile 
flask.
50.  Incubate for 2 hrs at 25°C with shaking.
51.   Check that cells have become smaller and rounder, under light 
microscope.
52.   Place cell culture on ice for 15 min.
 CRITICAL STEP: To maintain integrity and competency 
of cells, they must be kept at 4°C from this moment.
53.   Centrifuge cells for 5 min at 1600g, 4°C and remove 
supernatant.
54.   Resuspend cells on ice-cold, sterile water.
55.   Centrifuge for 5 min at 1600g, 4°C and remove supernatant.
56.   Repeat steps 54 and 55 twice more.
57.   Resuspend cells in 2 ml of ice-cold, filter-sterilized 30% 
Glycerol, 0.1M Lithium acetate (pH 4.9), which gives 
109 cells/ml.
58.   Prepare 50 µl cell aliquots in 1.5 ml sterile Eppendorf tubes, 
place aliquots on ice for 2 min. Each aliquot is for one 
transformation.
59. Store aliquots at -80°C immediately.
 PAUSE POINT: Cryopreserved cells can be stored at -80°C 
for at least 2 months.
Transformation of cryopreserved S. pombe cells (TIME: 30 min) 
60.   Thaw aliquots of synchronized, cryopreserved cells in dry 
block at 40°C for 2 min.
61.   For each transformation, add 2µl of 10 µg/µl denaturated her-
ring sperm DNA, 10 µl of HR template, and 2 µg of gRNA 
plasmid (~10 µl of standard mini-prep yield of 200ng/µl).
62.   Add 145 µl of 50% PEG4000, mix well and immediately 
incubate mix for 15 min at 43°C.
63.   Centrifuge cells for 3 min at 1600g, room temperature.
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64.   Remove supernatant and resuspend cells in 1 ml of EMM-N. 
 CRITICAL STEP: In the case of using auxotrophic 
mutant, we recommend the addition of 1/10 of usual 
concentration of relevant supplement. If using an h90 strain, 
use EMM with nitrogen to prevent sporulation.
65. Incubate at room temperature for 16 hours, without shaking.
66. Centrifuge cells for 3 min 1600g, room temperature.
67.   Remove supernatant and plate all cells on YES plates 
containing 100 µg/ml of Noursethricin.
68.   Incubate plates at 32°C for at least 4 days. In case not get-
ting successful deletions, longer incubations are sometimes 
required to allow small colonies to grow up.
69.   Re-streak smallest colonies onto YES plates. Cas9 expression 
is deleterious for cells, and re-streaking onto non-selective YES 
allows for elimination of the Cas9 plasmid.
 CRITICAL STEP: It is important to select the smallest 
colonies present (Figure 5): Large colonies are likely to 
emerge from transformants with mutations or rearrange-
ments of Cas912, and this problem is compounded in the 
large and unstable Cas9-sgRNA plasmid. Unpublished data 
suggest that the mutations happen during E. coli growth 
(large colony counts fluctuate between miniprep cultures 
but are quite stable within one culture), and may get worse 
with freeze-thaws of the plasmid (more negative large 
colonies in freeze-thawed plasmids).
Checking of deletions by colony PCR (TIME: 4 hrs) 
70. Prepare master mix for PCR reactions following table below:
Components Final  
concentration
Volume per 
reaction 
(25 µl total)
Cell colony 
 
 
TopTaq PCR Buffer 10x 
MgCl2 25 mM 
Primer mix (10 µM per primer) 
dNTPs mix (10 µmol per 
dNTP) 
Q Solution 5× 
H2O 
TopTaq DNA Polymerase  
(5 U/µl)
-- 
 
 
1× 
0.5 mM 
0.4 nM/each 
primer 
0.4 nmol/each 
1× 
-
Scoop cells 
with tip of 
pipette  
2.5 µl  
0.5 µl  
 
1 µl  
1 µl  
5 µl  
14.75 µl  
 
0.25 µl
71.   For each colony take a little biomass with 10 µl pipette tip and 
resuspend in PCR mix (with this polymerase there is no need 
to boil cells prior to PCR).
72.  Perform PCR following protocol below.
Cycles Temperature Duration
1 cycle  
35 cycles  
 
 
1 cycle
94ºC  
94ºC  
52ºC  
72ºC  
72ºC
2 min  
30 sec  
30 sec  
2min 30 sec  
7 min
73.   Add 5 µl of loading dye and load 10 µl of PCR product with 
loading dye mix on 0.7% agarose gel. The sizes of expected 
products are indicated in the output of CRISPR4P. (For success-
ful deletions, this will be ~200 bp and for wild-type, the size of 
target region to delete plus ~200 bp of flanking regions).
       OPTIONAL: add 0.5 µl of 10 mg/ml RNAse A solution to 
mix before loading to remove RNA that might complicate band 
visualization on gel.
To confirm the deletion junction, the PCR products can be sent 
for Sanger sequencing (the expected sequence surrounding 
the deletion junction is provided by CRISPR4P). Figure 3F 
provides an example of an agarose gel showing successful 
deletions.
Data and software availability
CRISPR4P software available from: bahlerlab.info/crispr4p
Latest source code: https://github.com/Bahler-Lab/crispr4p
Archived source code: DOI: 10.5281/zenodo.16468314 
License: MIT
Raw data are deposited in OSF (https://osf.io/5de22/) DOI: 
10.17605/OSF.IO/5DE2228
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low success. Therefore, the present work by the Zaratiegui and Bahler groups is important and will help to
solve some issues. It is expected that the improvements presented here will spread within the community.
A new selection is proposed for the Cas9 vector together with a new transformation method. A
straightforward web tool is added to the already long list of very useful resources developed over the
years by the Bahler lab.
The manuscript is well written and most of the time easy to read. Solving the following issues will improve
clarity.
In Figure 2, in « Table », the « numbers on the right » may be explained with a simple sentence.
Also, the naming « Table » seems a bit odd.
The colour code used in Figures 3 and 4 is different for the sg primers, which may be misleading to
some readers.
In Figure 5, the red arrows do not seem to point to anything while supposed to highlight small
colonies. Maybe using red circles will be better.
Figure 6 is not easy to understand. According to Figure 6A, there are 29 deletions with a
percentage of succesful deletions between 0 and 10% while the legend of Figure 6B suggests that
38 sgRNAs (36 sgRNAs #1 and 2 sgRNAs #2) did not yield to successful deletions. How is this
possible? A table in the supplementary data may be easier to read if showing for every ncRNAs:
the number of sgRNA tried and for each sgRNAs, the succes rate. The abscissa axis in Figure 6B
is especially very hard to read.
It would also be useful to discuss if the genome position matters and if the list of the
targeted ncRNAs roughly covers the whole genome.
The paragraph related to point mutations could provide more details or be removed and inserted
later on when more data are available.
Other comments.
It may be useful to mention that commercial kits are available to introduce the sgDNA into the
vector, for example the BioLabs Q5® Site-Directed Mutagenesis Kit that is inexpensive and
efficient.
The code on GitHub should be at least minimaly documented.
The version of Pombase used to build the database should be indicated.
There are still quite a few typos and mistakes, for examples:
on page 3 : The data to the right of each sgRNA indicates the numbers of other genomic sgRNA
sequences that share a given number of nucleotides (starting from the 5’ end of the PAM
sequence), isn’t « the number of genomic sequences » rather than the « the number of OTHER
genomic sequences »?
on page 6: rkk1-guided sgRNA should be rrk1-guided sgRNA
We have read this submission. We believe that we have an appropriate level of expertise to
confirm that it is of an acceptable scientific standard, however we have significant reservations,
as outlined above.
 No competing interests were disclosed.Competing Interests:
Author Response 21 Dec 2016
, Department of Genetics, Evolution and Environment, University College London, UKJürg Bahler
We thank the reviewers for their helpful and constructive comments. Below we provide a
point-by-pint response to the specific issues raised (pasted in italic).
In Figure 2, in « Table », the « numbers on the right » may be explained with a simple
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In Figure 2, in « Table », the « numbers on the right » may be explained with a simple
sentence. Also, the naming « Table » seems a bit odd.
We have changed the title of this Table to ‘Suggested sgRNAs’ in both the web tool and in Figure
2. In the figure legend, we have also provided an explanation for the numbers on the right of the
table.
The colour code used in Figures 3 and 4 is different for the sg primers, which may be
misleading to some readers.
We have now modified Figure 4 to match the color of the sgRNA primers with the ones in Figure 3.
In Figure 5, the red arrows do not seem to point to anything while supposed to highlight
small colonies. Maybe using red circles will be better.
We want to highlight the very smallest colonies because these are the most likely to be correct. In
the screen version of the figure, these colonies are visible. We have increased the contrast to
better visualize these colonies and now highlight small colonies using red circles as suggested.
Figure 6 is not easy to understand. According to Figure 6A, there are 29 deletions with a
percentage of succesful deletions between 0 and 10% while the legend of Figure 6B
suggests that 38 sgRNAs (36 sgRNAs #1 and 2 sgRNAs #2) did not yield to successful
deletions. How is this possible? A table in the supplementary data may be easier to read if
showing for every ncRNAs: the number of sgRNA tried and for each sgRNAs, the succes
rate. The abscissa axis in Figure 6B is especially very hard to read.
We understand that this was confusing. We have now corrected the x-axis of Figure 6A to indicate
that the lowest bin contains 1-10% of successful deletions (instead of 0-10%). We have also
clarified this in the figure legend. Here we only show the percentages of successful deletions. We
did not add numbers for any unsuccessful deletions, because we cannot be certain whether they
failed because of the sgRNA sequence, mutations in the plasmid, or any other reason. We now
also provide a Supplementary Table 2 showing the data from Figures 6A and 6B, which is cited in
the legend of Figure 6.
It would also be useful to discuss if the genome position matters and if the list of the
targeted ncRNAs roughly covers the whole genome
We have deleted ncRNA genes spread across all 3 chromosomes. We have now added an
additional section C to Figure 6 to show the genomic positions of all annotated ncRNA genes (grey
dots) and the ncRNA genes that we have successfully deleted (red dots). As for all genome
manipulations, there may of course be genomic regions which are less amenable to changes, e.g.
due to inaccessible chromatin.
The paragraph related to point mutations could provide more details or be removed and
inserted later on when more data are available.
We think that it is helpful to report at this point that it is also possible to get point mutations using
our CRISPR/Cas9 method. We will expand on this in a future update of the paper.
It may be useful to mention that commercial kits are available to introduce the sgDNA into
the vector, for example the BioLabs Q5® Site-Directed Mutagenesis Kit that is inexpensive
and efficient.
We know this kits, but have optimized the conditions for the polymerase indicated. A different
polymerase may require optimization of the initial PCR reaction, and the specific protocol provided
may no longer be valid in all details. Naturally, other users can experiment with different
procedures or kits, and we would be interested to hear of any alternatives that have been
implemented.
The code on GitHub should be at least minimaly documented.
We now provide basic documentation of the code in GitHub.
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We now provide basic documentation of the code in GitHub.
The version of Pombase used to build the database should be indicated.
The genome assembly is ASM294v2 and the annotation version 55, which is now specified in the
text.
There are still quite a few typos and mistakes, for examples:
on page 3 : The data to the right of each sgRNA indicates the numbers of other genomic
sgRNA sequences that share a given number of nucleotides (starting from the 5’ end of the
PAM sequence), isn’t « the number of genomic sequences » rather than the « the number of
OTHER genomic sequences »?
on page 6: rkk1-guided sgRNA should be rrk1-guided sgRNA
We have corrected these typos as suggested. 
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Rodriguez-Lopez and colleagues report improvements on CRISPR/Cas9-mediated genome editing in S.
 (fission yeast). Their work builds on a previous paper by Jacobs, Zaratiegui  (2014). In thispombe et al.
earlier paper, Jacobs  describe an expression vector for Cas9 and sgRNA that functions in et al. S. pombe
and demonstrate that mutagenesis and epitope-tagging is possible with this system.
 
Rodriguez-Lopez  now make several changes to improve the efficiency and the ease of use.et al.
The authors change the auxotrophic selection marker + in the Cas9/sgRNA plasmid to aura4
nourseothricin-resistance, which does not require a specific genetic background and allows
selection on rich medium.
Another group has recently implemented a fluoride export channel as another marker replacing 
+ on this plasmid, which also allows selection on rich medium and accelerates Cas9-mediatedura4
genome editing (Fernandez and Berro 2016). This also works well in our hands. I think it would be
great if the authors cited this paper, so that readers are aware of all the different possibilities.
Non-specific double-strand breaks created by Cas9 are always a concern, and it is important that
the plasmid is efficiently lost after successful genome modification. With the + version, 5-FOAura4
could be used for counterselection. Since expression of Cas9 impairs growth, I am assuming that
loss of the plasmid is very efficient, even without counterselection. However, if the authors happen
to have data on this, it would be nice to mention it. (For example, how many clones lost the plasmid
after one passage on non-selective medium?)
 
The authors have written a program to select specific sgRNA target regions. The program then
suggests primers for sgRNA cloning, as well as primers to delete a gene of interest and to check
for successful deletion.
This is generally very useful. When I tried the online version, I had no problem specifying a gene by
name, but finding sgRNA targets by entering specific coordinates did not work for me (using two
different browsers). My input caused an "Internal Server Error". It would be great if the authors
could look into this.
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could look into this.
The current implementation of the program suggests sgRNA targets based on specificity, but - as
the authors show - efficiency can be highly variable. For , there is no data available toS. pombe
indicate which target regions may be particularly efficient (and even in other organisms, information
is still scarce). I was wondering whether it could be useful to extend the program to allow
community feedback (i.e. when a researcher is using one of the suggested sgRNAs, she/he could
input how well this site worked). This would (a) avoid that several people try using target regions
that are not efficient, and (b) in the long run maybe allow it to determine which factors influence
efficiency. Obviously, some sort of quality control on the user input would be required (e.g. number
of successful genome modifications per how many clones tested, and a gel picture to support this),
which may make it too time-consuming for the Bähler Lab to curate.
 
The previous system needed digest of the Cas9/sgRNA plasmid with the restriction enzyme Csp
CI, which sometimes is inefficient. The authors have now solved this problem by amplification of
the entire 11 kb plasmid with primers that contain the specificity region, followed by ligation. This
seems more inconvenient than is necessary. However, the authors already mention that they work
on other improved strategies for the sgRNA cloning step that they will add to the paper as they are
implemented. I agree that this will be highly useful. 
 
The authors have further improved an existing protocol for  transformation to increaseS. pombe
transformation and deletion efficiency. Figure 5 shows that G1 synchronization greatly improves
transformation efficiency. If the authors happen to have data to which extent the cryopreservation
affects this result, it would be great if they could add it.
 
Overall, these are all highly useful changes - a clear improvement over the previous protocol. Motivation
and results are well described, and the step-by-step procedure is detailed and easy to follow.
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We thank the reviewer for her helpful, constructive comments. Our response to the specific issues
raised (pasted in italic) is presented below.
The authors change the auxotrophic selection marker ura4+ in the Cas9/sgRNA plasmid to
a nourseothricin-resistance, which does not require a specific genetic background and
allows selection on rich medium.
Another group has recently implemented a fluoride export channel as another marker
replacing ura4+ on this plasmid, which also allows selection on rich medium and
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replacing ura4+ on this plasmid, which also allows selection on rich medium and
accelerates Cas9-mediated genome editing (Fernandez and Berro, 2016). This also works
well in our hands. I think it would be great if the authors cited this paper, so that readers are
aware of all the different possibilities.
We missed this paper, thank you. We have now cited it in the introduction. A drawback of is that
fluoride selection requires a specific strain background.
Non-specific double-strand breaks created by Cas9 are always a concern, and it is
important that the plasmid is efficiently lost after successful genome modification. With the
ura4+ version, 5-FOA could be used for counterselection. Since expression of Cas9 impairs
growth, I am assuming that loss of the plasmid is very efficient, even without
counterselection. However, if the authors happen to have data on this, it would be nice to
mention it. (For example, how many clones lost the plasmid after one passage on
non-selective medium?)
We have checked 106 colonies after one pass onto non-selective media, and 88 (83%) of these
colonies have lost the plasmid passively.
The authors have written a program to select specific sgRNA target regions. The program
then suggests primers for sgRNA cloning, as well as primers to delete a gene of interest and
to check for successful deletion.This is generally very useful. When I tried the online version,
I had no problem specifying a gene by name, but finding sgRNA targets by entering specific
coordinates did not work for me (using two different browsers). My input caused an "Internal
Server Error". It would be great if the authors could look into this.
This bug has been corrected.
The current implementation of the program suggests sgRNA targets based on specificity,
but - as the authors show - efficiency can be highly variable. For S. pombe, there is no data
available to indicate which target regions may be particularly efficient (and even in other
organisms, information is still scarce). I was wondering whether it could be useful to extend
the program to allow community feedback (i.e. when a researcher is using one of the
suggested sgRNAs, she/he could input how well this site worked). This would (a) avoid that
several people try using target regions that are not efficient, and (b) in the long run maybe
allow it to determine which factors influence efficiency. Obviously, some sort of quality
control on the user input would be required (e.g. number of successful genome
modifications per how many clones tested, and a gel picture to support this), which may
make it too time-consuming for the Bähler Lab to curate.
Yes, we agree this is a good idea. As already mentioned in the paper, we are assembling a
database with all sgRNAs used, whether they worked or not, to help with learning the principles for
successful sgRNAs in . We may implement such a community system in a future updateS. pombe
of the paper.
The previous system needed digest of the Cas9/sgRNA plasmid with the restriction enzyme
CspCI, which sometimes is inefficient. The authors have now solved this problem by
amplification of the entire 11 kb plasmid with primers that contain the specificity region,
followed by ligation. This seems more inconvenient than is necessary. However, the authors
already mention that they work on other improved strategies for the sgRNA cloning step that
they will add to the paper as they are implemented. I agree that this will be highly useful. 
We are working on a method to avoid the PCR cloning, and once this is implemented will report it
in a future update of the paper.  
The authors have further improved an existing protocol for S. pombe transformation to
increase transformation and deletion efficiency. Figure 5 shows that G1 synchronization
greatly improves transformation efficiency. If the authors happen to have data to which
extent the cryopreservation affects this result, it would be great if they could add it.
We have not systematically checked to what extent cryopreservation helps, but it improves the
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We have not systematically checked to what extent cryopreservation helps, but it improves the
procedure in our hands. In the original paper describing the protocol, Suga et al. report that the
solution containing glycerol used as cryoprotectant improves efficiency: “These permeating agents
have an ability not only to cryoprotect cells but also to improve transformation efficiency, and
glycerol was a more effective agent for Sz. pombe cells. Thus, the thawed competent cells could
be used directly for transformation without removing the glycerol because the presence of glycerol
in the transformation mixture was important.”
But the G1 synchronization seems to make an even a bigger difference, and we have further
specified this in the legend of Figure 5. Transformation of synchronous cells consistently resulted
in 3-fold to over 1000-fold higher numbers of colonies than transformation of asynchronous cells. 
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